
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression
Xuehua Chen, Yongquan Huang, Hui Chen, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Xuehua Chen, Yongquan Huang, Hui Chen, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Showing 23 citing articles:
Application of lipid nanovesicle drug delivery system in cancer immunotherapy
Yinan Ding, Luhong Wang, Han Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Yinan Ding, Luhong Wang, Han Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA
Shushan Zhang, Yongquan Huang, Songying Pi, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Shushan Zhang, Yongquan Huang, Songying Pi, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Recent Advances in Zeolitic Imidazolate Frameworks as Drug Delivery Systems for Cancer Therapy
Y. Andrew Wang, Yixin Tang, Lei Guo, et al.
Asian Journal of Pharmaceutical Sciences (2025) Vol. 20, Iss. 1, pp. 101017-101017
Open Access | Times Cited: 1
Y. Andrew Wang, Yixin Tang, Lei Guo, et al.
Asian Journal of Pharmaceutical Sciences (2025) Vol. 20, Iss. 1, pp. 101017-101017
Open Access | Times Cited: 1
Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy
Mengzhen Yu, Yanwen Zhang, Meirong Fang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 743-743
Open Access | Times Cited: 35
Mengzhen Yu, Yanwen Zhang, Meirong Fang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 743-743
Open Access | Times Cited: 35
The application of nanoparticles in immunotherapy for hepatocellular carcinoma
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 19
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 19
Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date
Meng Yan, Hao Wang, Rui Wei, et al.
Archives of Pharmacal Research (2023) Vol. 47, Iss. 3, pp. 249-271
Closed Access | Times Cited: 18
Meng Yan, Hao Wang, Rui Wei, et al.
Archives of Pharmacal Research (2023) Vol. 47, Iss. 3, pp. 249-271
Closed Access | Times Cited: 18
Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency ablation via scavenging ROS
Meilin Yang, Die Liu, Yan Tan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Meilin Yang, Die Liu, Yan Tan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation‐Induced Tumor Relapse by Reprogramming Antitumor Immunity
Duo Wang, Tianqi Nie, Yifei Fang, et al.
Advanced Healthcare Materials (2025)
Open Access
Duo Wang, Tianqi Nie, Yifei Fang, et al.
Advanced Healthcare Materials (2025)
Open Access
Caveolin-1 promotes glioma proliferation and metastasis by enhancing EMT via mediating PAI-1 activation and its correlation with immune infiltrates
Zhaoxiang Wang, Gang Chen, Debin Yuan, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24464-e24464
Open Access | Times Cited: 3
Zhaoxiang Wang, Gang Chen, Debin Yuan, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24464-e24464
Open Access | Times Cited: 3
Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3
Evodiamine encapsulated by hyaluronic acid modified zeolitic imidazolate framework-8 for tumor targeted therapy
Qiang Zhou, Dandan Xie, Kui Wang, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 3
Qiang Zhou, Dandan Xie, Kui Wang, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 3
Radiofrequency ablation: mechanisms and clinical applications
Jianhua Wu, Zhiyuan Zhou, Yuanwen Huang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 3
Jianhua Wu, Zhiyuan Zhou, Yuanwen Huang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 3
Nanoparticle Delivery of Active Traditional Chinese Medicine Ingredients: A New Strategy for the Treatment of Liver Cancer
Miaodong Wang, Peichun Peng, Zeshan Chen, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 24, Iss. 13, pp. 1630-1644
Closed Access | Times Cited: 8
Miaodong Wang, Peichun Peng, Zeshan Chen, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 24, Iss. 13, pp. 1630-1644
Closed Access | Times Cited: 8
Can arsenic do anything good? Arsenic nanodrugs in the fight against cancer – last decade review
Izabela Komorowicz, Anetta Hańć
Talanta (2024) Vol. 276, pp. 126240-126240
Closed Access | Times Cited: 2
Izabela Komorowicz, Anetta Hańć
Talanta (2024) Vol. 276, pp. 126240-126240
Closed Access | Times Cited: 2
Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
Shilun Wu, Zhuxin Li, Changyu Yao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Shilun Wu, Zhuxin Li, Changyu Yao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Cecropin-Loaded Zeolitic Imidazolate Framework Nanoparticles with High Biocompatibility and Cervical Cancer Cell Toxicity
Jingwen Jiang, Yanzhu Pan, Jinyao Li, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4364-4364
Open Access | Times Cited: 9
Jingwen Jiang, Yanzhu Pan, Jinyao Li, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4364-4364
Open Access | Times Cited: 9
All Roads Lead to Rome: Comparing Nanoparticle‐ and Small Molecule‐Driven Cell Autophagy
Xiaofei Zhou, Iliana E. Medina-Ramírez, Gaoxing Su, et al.
Small (2024) Vol. 20, Iss. 34
Closed Access | Times Cited: 1
Xiaofei Zhou, Iliana E. Medina-Ramírez, Gaoxing Su, et al.
Small (2024) Vol. 20, Iss. 34
Closed Access | Times Cited: 1
Maximizing Arsenic Trioxide's Anticancer Potential: Targeted Nanocarriers for Solid Tumor Therapy
Shiqi Yang, Faisal Raza, Kunwei Li, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 241, pp. 114014-114014
Closed Access | Times Cited: 1
Shiqi Yang, Faisal Raza, Kunwei Li, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 241, pp. 114014-114014
Closed Access | Times Cited: 1
Nanocarrier-Based Delivery of Arsenic Trioxide for Hepatocellular Carcinoma Therapy
Jiang Sun, Mengying Cheng, Tingxian Ye, et al.
Nanomedicine (2022) Vol. 17, Iss. 26, pp. 2037-2054
Closed Access | Times Cited: 6
Jiang Sun, Mengying Cheng, Tingxian Ye, et al.
Nanomedicine (2022) Vol. 17, Iss. 26, pp. 2037-2054
Closed Access | Times Cited: 6
Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
Yingqi Feng, Wei Wu, Muzi Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Yingqi Feng, Wei Wu, Muzi Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation
Feilong Ye, Lulu Xie, Licong Liang, et al.
Journal of interventional medicine (2023) Vol. 6, Iss. 4, pp. 160-169
Open Access | Times Cited: 1
Feilong Ye, Lulu Xie, Licong Liang, et al.
Journal of interventional medicine (2023) Vol. 6, Iss. 4, pp. 160-169
Open Access | Times Cited: 1
SOX10 promotes the malignant biological behavior of basal-like breast cancer cells by regulating EMT process
Kai Yang, Fen Yun, Lin Shi, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e23162-e23162
Open Access | Times Cited: 1
Kai Yang, Fen Yun, Lin Shi, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e23162-e23162
Open Access | Times Cited: 1
Correction to: Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression
Xuehua Chen, Yongquan Huang, Hui Chen, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Xuehua Chen, Yongquan Huang, Hui Chen, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 1